In this study, we demonstrated that blocking XBP-1 decreased the proliferation of IECs during endotoxemia and that by restraining miR-674-5p expression, enhanced XBP-1 could accelerate IEC proliferation, especially in the crypts, in endotoxemia-induced intestinal injury. Here, XBP1 is linked to serum lipopolysaccharide activity.